Anti-angiogenesis therapy and gap junction inhibition reduce MDA-MB-231 breast cancer cell invasion and metastasis in vitro and in vivo.
about
Gap junctions and cancer: communicating for 50 years.Dysregulation of cell-cell interactions in brain arteriovenous malformations: A quantitative proteomic study.Lower expression of miR-218 in human breast cancer is associated with lymph node metastases, higher grades, and poorer prognosis.PAD1 promotes epithelial-mesenchymal transition and metastasis in triple-negative breast cancer cells by regulating MEK1-ERK1/2-MMP2 signaling.Mind the Gaps in Tumor Immunity: Impact of Connexin-Mediated Intercellular Connections.Nano-Hydroxyapatite-Derived Drug and Gene Co-Delivery System for Anti-Angiogenesis Therapy of Breast Cancer.Electronic Cigarette Smoke Impairs Normal Mesenchymal Stem Cell Differentiation.Dysregulated connexin 43 in HER2-positive drug resistant breast cancer cells enhances proliferation and migration.Mechanistic modeling quantifies the influence of tumor growth kinetics on the response to anti-angiogenic treatment.Collateral Damage Intended-Cancer-Associated Fibroblasts and Vasculature Are Potential Targets in Cancer Therapy.Untargeted metabolomics reveals distinct metabolic reprogramming in endothelial cells co-cultured with CSC and non-CSC prostate cancer cell subpopulations.Urokinase-derived peptide UP-7 suppresses tumor angiogenesis and metastasis through inhibition of FAK activation.Role of the Nervous System in Tumor Angiogenesis.Genetics: Transcribing for the enemy.Inhibition of tumor formation and metastasis by a monoclonal antibody against lymphatic vessel endothelial hyaluronan receptor 1mouse study identifies tumour growth kinetics as biomarkers for the outcome of anti-angiogenic treatment
P2860
Q37613777-3B772FD9-65A5-448F-8D56-632A03E6E214Q38382439-31963AC1-813E-49DA-8585-5CE550E7B875Q38429163-35526AD5-B51B-4D4D-8CD6-DD90B8E7F57FQ38606630-A1D4FED9-2926-4999-9362-728BCDF7B2A8Q41619582-1A586554-6E63-4DBA-BA6C-2C791729EB33Q42705465-5FA11203-2CC1-48BD-BC25-022D653ED111Q46272932-E86A544F-F1F0-4225-A575-4408F3F5E674Q47220416-282AE43A-B36E-45B2-98E2-34A717882039Q47228068-350BE4B3-302C-4207-BB4B-A48237AB52A9Q48049656-DC08ADD4-AE38-4844-A9AD-E7ECD0321A8EQ50146366-FC0F7C4A-CA1D-4ACC-8640-38E058DDD2D7Q52668185-45755392-F7E5-4AE6-A95E-2BB1DB5CCCF9Q52675438-E11897F7-FBB4-42C9-9E33-B99D44AF687AQ54540610-82BA290F-474A-48AA-856B-73DA3E0A9303Q58701870-27E2F45C-DDAD-410E-A077-7707997ED9DDQ58718463-EE122F66-6E63-4BE2-9AD1-0BDE15C351F5
P2860
Anti-angiogenesis therapy and gap junction inhibition reduce MDA-MB-231 breast cancer cell invasion and metastasis in vitro and in vivo.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Anti-angiogenesis therapy and ...... tastasis in vitro and in vivo.
@ast
Anti-angiogenesis therapy and ...... tastasis in vitro and in vivo.
@en
type
label
Anti-angiogenesis therapy and ...... tastasis in vitro and in vivo.
@ast
Anti-angiogenesis therapy and ...... tastasis in vitro and in vivo.
@en
prefLabel
Anti-angiogenesis therapy and ...... tastasis in vitro and in vivo.
@ast
Anti-angiogenesis therapy and ...... tastasis in vitro and in vivo.
@en
P2093
P2860
P356
P1433
P1476
Anti-angiogenesis therapy and ...... tastasis in vitro and in vivo.
@en
P2093
Aida Ibrik
Jamal El-Saghir
Marwan El-Sabban
Nabil El-Zein
Sara Al-Ghadban
Zahraa Awada
P2860
P2888
P356
10.1038/SREP12598
P407
P50
P577
2015-07-28T00:00:00Z
P5875
P6179
1026370404